DAC suppressed tumor growth and restored immune control by increasing the numbers and functionality of tumor-infiltrating CD8+ T cells and NK cells, CD8+ tissue-resident memory T cells and CD103+ DCs with cross-priming capacity, and by reducing the number of MDSCs (Zhang et al, 2024). Here, CD8A is linked to neoplasm.